Garcia, M. M., Valiente, M., SepĂșlveda, J. M., Pineda, E., Vaz-Salgado, M. Ă., Lendinez-Sanchez, G., Velilla, G., Mazariegos-Rubi, M., Valduvieco, I., Castro-Henriques, M., Cano, L., Marcus, S. G. (2026). Azeliragon, a RAGE inhibitor, plus temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Final results from a dose-finding phase in the CAN-201 NDG trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2015